#	Pagina
attuale pagina	/open-h2020/projects/226155/index.html

Opendata, web and dolomites

cmRNAbone SIGNED

3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

cmRNAbone project word cloud

Explore the words cloud of the cmRNAbone project. It provides you a very rough idea of what is the project "cmRNAbone" about.

sensory experts preclinical medical therapies neurogenesis candidate dosage clinically consisting formulations enormous vegf patients mechanisms functional tools loaded human printing cmrnas group proof trial phosphate synthesized printed keeping nations industrialized ageing preparing lipids ratio clinical regulatory intrinsic bone therapeutic loading osteoporosis peptides cmrnabone auditing facilities bmp7 ink style ingrowth sema3a deciphering cells calcium promises neurons fabrication amenable endothelial rnas strategies hyaluronan solution vivo chemically laminin patient optimizing until vasculogenesis fragile extrusion combination life formulated nanocapsules vitro printer due create gmp presenting 1st realized bioprinting socio fracture overreaching osteoinductivity release solutions polysaccharide pdgf vectors bb conjunction commercial modified economic effort 3d guiding injuries biomaterial osteogenesis traumatic failed regenerative

Project "cmRNAbone" data sheet

The following table provides information about the project.

Coordinator	AO-FORSCHUNGSINSTITUT DAVOS Organization address address: CLAVADELERSTRASSE 8 city: DAVOS PLATZ postcode: 7270 website: www.aofoundation.org contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Switzerland [CH]
Total cost	6˙256˙758 €
EC max contribution	6˙256˙758 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SC1-2019-Single-Stage-RTD
Funding Scheme	RIA
Starting year	2020
Duration (year-month-day)	from 2020-01-01 to 2023-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	AO-FORSCHUNGSINSTITUT DAVOS AO-FORSCHUNGSINSTITUT DAVOS Organization address address: CLAVADELERSTRASSE 8 city: DAVOS PLATZ postcode: 7270 website: www.aofoundation.org contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (DAVOS PLATZ)	coordinator	710˙750.00
2	UNIVERSITE DE BORDEAUX UNIVERSITE DE BORDEAUX Organization address address: PLACE PEY BERLAND 35 city: BORDEAUX postcode: 33000 website: www.nouvelle-univ-bordeaux.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (BORDEAUX)	participant	1˙117˙558.00
3	UNIVERSITEIT MAASTRICHT UNIVERSITEIT MAASTRICHT Organization address address: Minderbroedersberg 4-6 city: MAASTRICHT postcode: 6200 MD website: http://www.maastrichtuniversity.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (MAASTRICHT)	participant	999˙748.00
4	UNIVERSITAT BASEL UNIVERSITAT BASEL Organization address address: PETERSPLATZ 1 city: BASEL postcode: 4051 website: www.unibas.ch contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CH (BASEL)	participant	659˙570.00
5	ETHRIS GMBH ETHRIS GMBH Organization address address: SEMMELWEISSTR. 3 city: PLANEGG postcode: 82152 website: www.ethris.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (PLANEGG)	participant	490˙526.00
6	EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH Organization address address: HEINRICH-HERTZ-ALLEE 1 city: ST INGBERT postcode: 66386 website: www.eurice.eu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (ST INGBERT)	participant	457˙500.00
7	OZ BIOSCIENCES SAS OZ BIOSCIENCES SAS Organization address address: PARC SCIENTIFIQUE ET TECHNOLOGIQUE DE LUMINY CASE 922 BAT CCIMP city: MARSEILLE postcode: 13288 website: www.ozbiosciences.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (MARSEILLE)	participant	447˙750.00
8	FUNDACION CIDETEC FUNDACION CIDETEC Organization address address: PASEO MIRAMON 196 PARQUE TECNOLOGICO DE MIRAMON city: SAN SEBASTIAN postcode: 20014 website: www.cidetec.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (SAN SEBASTIAN)	participant	443˙500.00
9	KUROS BIOSCIENCES BV KUROS BIOSCIENCES BV Organization address address: PROFESSOR BRONKHORSTLAAN 10 G 48 city: BILTHOVEN postcode: 3723 MB website: www.xpand-biotech.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (BILTHOVEN)	participant	435˙138.00
10	FUNDACION IDONIAL FUNDACION IDONIAL Organization address address: AVENIDA JARDIN BOTANICO 1345 PARQUE CIENTIFICO Y TECNOLOGICO ZONA INTRA city: GIJON postcode: 33203 website: www.prodintec.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (GIJON)	participant	310˙500.00
11	QBEX GMBH QBEX GMBH Organization address address: ST. VEITER RING 1A city: KLAGENFURT postcode: 9020 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (KLAGENFURT)	participant	184˙216.00

Map

Project objective

Due to life style changes and ageing of our industrialized nations, bone traumatic injuries and osteoporosis induced fragile fracture are an enormous medical and socio-economic challenge. State-of-the-art therapies have failed until now in keeping their promises of reliable bone regenerative solutions. The cmRNAbone project aim to create a novel bone regenerative therapeutic approach based on combination of chemically modified RNAs (cmRNAs)-vectors embedded in a 3D-printed guiding biomaterial ink tailored to patients need. To achieve our goal, sema3a, vegf, pdgf-bb and bmp7 cmRNAs targeting neurogenesis, vasculogenesis and osteogenesis will be synthesized, vectors based on lipids and polysaccharide nanocapsules for the delivery of cmRNAs will be developed. A functional Hyaluronan-Calcium Phosphate biomaterial ink that 1) can be loaded with cmRNAs-vectors and release them, 2) having intrinsic osteoinductivity and presenting laminin-derived peptides for guiding sensory neurons and endothelial cells ingrowth, and 3) being amenable to an extrusion-based 3D-bioprinting process will be formulated in conjunction to a 3D-printer for fabrication of patient specific regenerative solution. In the following step, a large effort will focus on deciphering regenerative mechanisms and optimizing dosage and ratio of cmRNAs, loading of cmRNAs-vectors in the ink, 3D-printing, etc, to demonstrate regenerative capabilities in vitro and in vivo. Selected candidate formulations will be taken to clinically relevant preclinical proof of concepts. Finally, an overreaching effort on preparing a 1st in human trial will be taken, consisting on partners facilities auditing and clinical experts group support, etc, to ensure that GMP-like production for all regenerative tools, and regulatory and commercial strategies are realized.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CMRNABONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CMRNABONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More